Viatris (VTRS) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026)
Viatris (VTRS) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -18.34% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.19% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.59% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 41.67% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -7.68% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -1.31% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.98% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.94% |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | -8.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.68% |
| Mar 31, 2026 | -4.09% |
| Dec 31, 2025 | -1.95% |
| Sep 30, 2025 | -1.89% |
| Jun 30, 2025 | -0.75% |
| Mar 31, 2025 | -2.68% |
| Dec 31, 2024 | -3.39% |
| Sep 30, 2024 | -8.53% |
| Jun 30, 2024 | -10.75% |
| Mar 31, 2024 | -9.96% |
| Dec 31, 2023 | -8.76% |
| Sep 30, 2023 | -3.70% |
| Jun 30, 2023 | -3.27% |
| Mar 31, 2023 | -4.52% |
| Dec 31, 2022 | -5.15% |
| Sep 30, 2022 | -2.41% |
| Jun 30, 2022 | -2.76% |
| Mar 31, 2022 | -2.98% |
| Dec 31, 2021 | -7.84% |
| Dec 31, 2020 | 60.96% |